Make Twice the Impact Right Now
Make Twice the Impact Right Now
Our Double the Hope Match Challenge is underway, but not for long. From now until Oct. 23, your gift can have double the impact on advancing research and brain health discoveries, as well as helping to provide care and support to those impacted by Alzheimer’s disease.
Donate NowMeet Our Corporate Partners
Reaching our vision of a world without Alzheimer’s is a team effort. The generous support of our corporate partners allows us to serve more families and to accelerate research toward methods of treatment, prevention and — ultimately — a cure.
Learn how to become a national corporate partner.
Featured Corporate Partner
Edward Jones: Invested in Families and a Future Without Alzheimer's
Since 2016, Edward Jones has contributed more than $63 million through firm contributions and associate, client and community giving to support the Alzheimer's Association.
Visionary Partners
Accelerator Partners
Biogen
Costco
Genentech - A Roche Company/Roche Diagnostics
Novo Nordisk
Catalyst Partners
AARP
AbbVie
Acumen Pharmaceuticals
Alzheon
Athira Pharma, Inc.
AWS
Beckman Coulter Life Sciences
Bristol Myers Squibb
C2N Diagnostics
Cogstate
GE HealthCare
Johnson & Johnson
Lundbeck
Molina Healthcare
Prothena Biosciences
UnitedHealth Group
Volta Oil
Mission Leader Partners
Diagnostic and Pharmaceutical Corporate Donors
No contribution from any entity impacts the Alzheimer's Association decision-making, nor our positions on issues related to people living with Alzheimer’s, other dementia and their families. Total contributions from the pharmaceutical industry make up just over 1.5% of the Association’s total contributed revenue. View the report that discloses pharmaceutical, biotech, medical device, medical application, medical foods, nutraceutical company and clinical research contributions during the past fiscal year.